Hyoung J. Kang

Professor
Department of Pediatrics, Seoul National University College of Medicine, Seoul National University Cancer Research Institute& Wide River Institute of Immunology, Seoul National University Children's Hospital

Presentation(s):

• OC 15.1 - PREVAPIX-ALL: Phase 3 Study of the Safety and Efficacy of Apixaban for Thromboprophylaxis versus Standard of Care in Newly Diagnosed Pediatric Acute Lymphoblastic Leukemia or Lymphoma (ALL/LL)

  Sunday, July 10, 2022
  10:45 AM – 11:00 AM